Developing a molecular “fingerprint” as a non-invasive screen for breast cancer
This translational grant proposes to build on exciting BCRT-funded science that has led to the identification of two RNA markers in the blood, which together may be able to indicate whether a woman has breast cancer or not. We now want to study additional markers to see if, using a combination of markers, we can make our test more accurate and ready for larger scale trials. We will further refine our methods to detect these markers in the blood, and then we will measure them in increasing numbers of breast cancer patients, compared to blood samples from healthy women. We will also assess these markers before and after surgical removal of breast tumours. By combining these markers with the patient’s clinical data, we hope to define a simple blood test that can be used in screening for breast cancer or to indicate whether a breast cancer patient has relapsed.
Keep reading
View all
Can Functional MRI of the Brain help us understand Brain Fog in Women with Breast Cancer?
Up to 70% of women with breast cancer experience cognitive difficulties, but scientists still don't fully understand why this happens. Without a clear understanding of the underlying cause, it is d...
Exploring Better Breast Imaging for Women in Aotearoa New Zealand
Mammograms save lives by finding breast cancer early. But they do not work equally well for everyone.For women with very dense breast tissue, cancer can be harder to see on a standard mammogram. Th...
From Evidence to Action: Expanding the ‘Not a One-Size-Fits-All’ Breast Cancer Screening Model for Aotearoa New Zealand.
Breast cancer screening in Aotearoa New Zealand does not benefit all women equally. Many cancers are still found outside the national screening programme, and Māori and Pacific women can face delay...
